Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) Ending Cash Balance (2017 - 2026)

Updated

Amneal Pharmaceuticals' Ending Cash Balance was $180.25 million in Q3 2026, down 24.4% from $238.41 million a year earlier but up 29.1% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Ending Cash Balance (2017 - 2026) Analysis & Trends

For FY2025, Ending Cash Balance at Amneal Pharmaceuticals came in at $312.94 million, up 164.3% from FY2024.

  • Ending Cash Balance has now increased for three consecutive years, though with a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
  • In earlier years, Ending Cash Balance was $118.42 million in FY2024 (+19.5%), $99.11 million in FY2023 (+181.3%), $35.23 million in FY2022 (-86.3%) and $256.74 million in FY2021 (-26.0%).
  • Quarterly Ending Cash Balance has moved between $35.23 million (Q4 2022) and $312.94 million (Q4 2025) over five years.
  • Compared with a year earlier, Ending Cash Balance was higher in seven of the last eight quarters, with growth averaging 91.3%.
  • The best year-over-year quarter for Ending Cash Balance over five years was Q3 2025 (growth of 204.3%); the worst was Q4 2022 (a decline of 86.3%).
  • Per Business Quant data, AMRX's Ending Cash Balance in the three quarters before Q3 2026 was $139.62 million (Q2 2026), $204.41 million (Q1 2026) and $312.94 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 16.91 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 10.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 7.94 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.88 Bn
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn 180.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 180.25 Mn
Jun 30, 2026 139.62 Mn
Mar 31, 2026 204.41 Mn
Dec 31, 2025 312.94 Mn
Sep 30, 2025 238.41 Mn
Jun 30, 2025 83.67 Mn
Mar 31, 2025 68.39 Mn
Dec 31, 2024 118.42 Mn
Sep 30, 2024 78.35 Mn
Jun 30, 2024 49.62 Mn
Mar 31, 2024 51.62 Mn
Dec 31, 2023 99.11 Mn
Sep 30, 2023 95.61 Mn
Jun 30, 2023 114.58 Mn
Mar 31, 2023 151.07 Mn
Dec 31, 2022 35.23 Mn
Sep 30, 2022 95.89 Mn
Jun 30, 2022 98.18 Mn
Mar 31, 2022 216.55 Mn
Dec 31, 2021 256.74 Mn
API Access

Amneal Pharmaceuticals Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=AMRX&period=max&api_key=YOUR_API_KEY